Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells

被引：0
|
作者：
Cottard, Felicie [1 ]
Asmane, Irene [2 ]
Erdmann, Eva [1 ]
Bergerat, Jean-Pierre [2 ]
Kurtz, Jean-Emmanuel [2 ]
Ceraline, Jocelyn [1 ]
机构：
[1] INSERM U1113, Strasbourg, France
[2] Strasbourg Univ Hosp, Haematol & Oncol Unit, INSERM U1113, Strasbourg, France
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2117
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells
    Cottard, Felicie
    Asmane, Irene
    Erdmann, Eva
    Bergerat, Jean-Pierre
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    PLOS ONE, 2013, 8 (05):
  • [2] Gene expression in prostate cancer bone metastases in relation to expression of the androgen receptor and one of its constitutively active variants
    Hornberg, E.
    Bergh, A.
    Widmark, A.
    Antti, H.
    Wikstrom, P.
    BONE, 2011, 48 (01) : S29 - S30
  • [3] Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer
    Schweizer, M. T.
    Plymate, S. R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (08) : 903 - 906
  • [4] Associations of Saposin C, Src, and Androgen Receptor Upregulate the Expression and Function of Androgen Receptor in Human Prostate Cancer Cells
    Ding, Yan
    Wang, Xiaoling
    Xu, Aihui
    Xu, Xia
    Tian, Keli
    Young, Charles Y. F.
    Yuan, Huiqing
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (03) : 818 - 828
  • [5] Constitutively active androgen receptor variant detected in a human prostate cancer
    Céraline, J
    Cruchant, MD
    Erdmann, E
    Erbs, P
    Kurtz, JE
    Duclos, B
    Jacqmin, D
    Chopin, D
    Dufour, P
    Bergerat, JP
    HORMONAL CARCINOGENESIS IV, 2005, : 336 - 342
  • [6] Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
    Watson, Philip A.
    Chen, Yinan F.
    Balbas, Minna D.
    Wongvipat, John
    Socci, Nicholas D.
    Viale, Agnes
    Kim, Kwanghee
    Sawyers, Charles L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (39) : 16759 - 16765
  • [7] Androgen receptor variants in prostate cancer
    Schreyer, Edwige
    Barthelemy, Philippe
    Cottard, Felicie
    Madi-Berthelemy, Pauline Ould
    Schaff-Wendling, Frederique
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    M S-MEDECINE SCIENCES, 2017, 33 (8-9): : 758 - 764
  • [8] Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
    Dehm, Scott M.
    Schmidt, Lucy J.
    Heemers, Hannelore V.
    Vessella, Robert L.
    Tindall, Donald J.
    CANCER RESEARCH, 2008, 68 (13) : 5469 - 5477
  • [9] Cytidine analogs upregulate androgen receptor expression and induce apoptosis in human prostate cancer cells in vitro.
    Izbicka, E
    Davidson, K
    Yoneda, T
    Williams, P
    VonHoff, DD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T735 - T735
  • [10] The Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells
    Richmond, Oliver
    Ghotbaddini, Maryam
    Allen, Cidney
    Walker, Alice
    Zahir, Shokouh
    Powell, Joann B.
    PLOS ONE, 2014, 9 (04):
12345